Login · Contact

Akorn Pharmaceuticals

GO
Timeline
2015
Akorn Receives FDA Approval for Phenylephrine HCl Ophthalmic Solution read more...
2014
Akorn Acquires Xopenex® (levalbuterol HCI) Inhalation Solution read more...
Akorn Acquires Hi-Tech Pharmacal. read more...
Akorn Acquires VersaPharm. read more...
2013-2014
Akorn Acquires Four Branded Ophthalmic Products: Zioptan®, CosoptPF/Cosopt®, AzaSite®, and Betimol®.
2012
Generic Vancocin® is approved and launched.
2011
Advanced Consumer Health is acquired to expand presence in a $1.2 billion over-the-counter eye care market. read more...
A Minority Stake in Aciex Therapeutics is acquired providing access to an innovative ophthalmic pipeline. read more...
Entered into agreement to acquire assets from Kilitch Drugs of India to expand manufacturing of sterile injectables and global reach. read more...
Nembutal®, a Schedule II controlled drug, Diuril® and Cogentin® are acquired from Lundbeck Pharma.
2010
The Akorn R&D Center in Skokie, IL is opened to provide leading edge capabilities for the development of new and generic pharmaceuticals.
2008
Corporate Headquarters are moved to Lake Forest, Illinois.
Warehousing is relocated to Gurnee, Illinois.
Akten® (lidocaine HCI ophthalmic gel) 3.5%, Akorn's first internally developed NDA indicated for topical ocular anesthesia is launched.
2007
Akorn, Inc. is listed on the NASDAQ exchange.
2004
Akorn Inc. and Strides Arcolab Ltd. enter into a joint venture as Akorn-Strides, LLC.
2002
Paremyd® (hydroxyamphetamine hydrobromide and tropicamide, ophthalmic solution), a convenient one-drop dilation agent is launched.
1998
Advanced Remedies Incorporated is acquired in Somerset, New Jersey, a division of Sidmak laboratories and manufacturer of sterile ophthalic ointments and solutions.
1997
Akorn Inc. is founded. Corporate headquarters and distribution offices are moved to Buffalo Grove, Illinois.
Indocyanine green, now IC-Green®, Akorn's first New Drug Application (NDA) ophthalmic drug for retina diagnostic imaging, is acquired from Becton Dickinson (BD).
1996
Taylor Pharmacal Company begins operating under the name of Akorn Manufacturing.
Pasadena Research Laboratories in Pasadena, California is acquired along with its injectable line of products.
1994
The Grand facility in Decatur is expanded to add ophthalmic filling operations.
1992
The Taylor family sells Taylor Pharmacal Company to Akorn Inc., a Louisiana based ophthalmic sales and distribution company, that owns ophthalmic products under the Akorn Ophthalmics label.
1977
The Wyckles facility in Decatur, Illinois is constructed to provide packaging and warehouse operation and to allow expansion of the filling and laboratory testing areas at the Grand facility.
1971
Akorn Ophthalmics is founded in Abita Springs, Louisiana
1953
The Grand facility in Decatur, Illinois is constructed to provide a filling and packaging location for the manufacture of pharmaceutical products.
1948
Taylor Pharmacal is founded by Guy Taylor and his two sons in Decatur Illinois.